Moreover, given the frequent concurrence of PCOS and InsR, and the mechanistic similarities between these two conditions, it is crucial to investigate the clinical relevance of other natural molecules with insulin-sensitizing activity. The gene discussed is INS; the disease is polycystic ovary syndrome.